On Jul. 29, 2022, the U.S. Department of Health and Human Services (HHS), in collaboration with the U.S….
On Jul. 28, 2022, AlphaFold, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI), announced they we’re releasing predicted…
On Jul. 28, 2022, the World Health Organization (WHO) released new guidelines for the use of long-acting injectable…
On Jul. 28, 2022, the Allen Institute announced a newly released dataset of 1.2M cells from brain donors…
On Jul. 27, 2022, BD (Becton, Dickinson) announced their newly developed molecular polymerase chain reaction (PCR) test for…
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
On Jul. 27, 2022, the Centers for Disease Control and Prevention (CDC) announced that it had identified for…
On Jul. 27, 2022, Pfizer and BioNTech announced that the companies had initiated a randomized, active-controlled, observer-blind, Phase…
On Jul. 26, 2022, Novavax announced that the Australian Therapeutic Goods Agency had granted expanded approval for provisional…
On Jul. 26, 2022, Novavax announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketing approval from…
COVID-19 Vacations Redux iIlustrates once again the pits and perils vacation travelers face as they begin their Summer…
On Jul. 23, 2022, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended…
On Jul. 22, 2022, a team of scientists announced they had generated genome sequences from 6,000- and 3,300-year-old…
On Jul. 22, 2022, the Centers for Disease Control and Prevention (CDC) released a MMWR report that summarized…
On Jul. 22, 2022, Gilead Sciences announced that the Committee for Medicinal Products for Human Use (CHMP) of…
On Jul. 21, 2022, the New York State Department of Health confirmed that a case of paralytic poliomyelitis…
On Jul. 19, 2022, Moderna said that Australia’s drug regulator Therapeutic Goods Administration (TGA) has provisionally approved its…
On Jul. 19, 2022, the National Institutes of Health (NIH) announced that although COVID-19 booster vaccinations in adults…
On Jul. 19, 2022, Novavax announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee…
On Jul. 19, 2022, Novavax announced that it had signed agreements with its partner, SK bioscience, for the…
On Jul. 19, 2022, Yale scientists announced they had developed a novel Omicron-specific mRNA vaccine that offers superior…
On Jul. 19, 2022, Gilead Sciences and the European Commission announced a new joint procurement agreement (JPA) that…
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 15, 2022, The largest sustained decline in childhood vaccinations in approximately 30 years has been recorded…
On Jul 14. 2022, Aegis Sciences announced it is was authorized to begin testing for mpox using the…
On Jul. 14, 2022, Health Canada announced it had authorized the use of the Moderna Spikevax COVID-19 vaccine…
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability of the company’s lab-developed…
On Jul. 13, 2022, Moderna announced it has now demonstrated significantly higher antibody titers against all tested variants,…
On Jul. 13, 2022, Novavax announced that its COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received emergency use authorization from…
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…